<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03602209</url>
  </required_header>
  <id_info>
    <org_study_id>No. 14-198</org_study_id>
    <nct_id>NCT03602209</nct_id>
  </id_info>
  <brief_title>Short vs. Long Antibiotic Treatment of Implant-free Osteoarticular Infections</brief_title>
  <official_title>Short vs. Long Antibiotic Treatment of Implant-free Osteoarticular Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators tested the working hypothesis if 4 weeks of systemic antibiotic treatment
      in implant-related orthopaedic infections is non-inferior to 6 weeks after complete removal
      of the infected implant. Randomization 1:1.

      The study is completed. It halted prematurely and will not resume; participants are no longer
      being examined or receiving intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Former description of the study (now completed)

      Osteoarticular infections related to orthopaedic implants are associated with substantial
      morbidity, prolongation of hospital stay, and additional costs. Due to the increasing number
      of patients with orthopaedic implants in Switzerland, similar to the rest of Europe and
      elsewhere, the number of infections is expected to increase. While the surgical treatment of
      these infections has been well studied, the ideal duration of antibiotic therapy after
      removal (explantation) of the infected implant remains unknown. For almost 40 years, the
      recommended total duration of post-explantation antibiotic therapy has been 6 weeks. This
      recommendation is based on expert's personal experience rather than on prospective randomized
      studies. Shorter treatment would decrease antibiotic-related adverse events and costs
      hospital stay for patients awaiting an eventual reinsertion of a new implant. If physicians
      and surgeon prescribe antibiotics for 6 weeks, this duration should be at least supported by
      evidence.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2015</start_date>
  <completion_date type="Actual">May 18, 2018</completion_date>
  <primary_completion_date type="Actual">February 28, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Remission of infection</measure>
    <time_frame>12 months</time_frame>
    <description>Clinical evaluation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>12 months</time_frame>
    <description>Clinical adverse events</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Implant Infection</condition>
  <arm_group>
    <arm_group_label>4 weeks of treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>6 weeks of treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Removal of infected implant</intervention_name>
    <arm_group_label>4 weeks of treatment</arm_group_label>
    <arm_group_label>6 weeks of treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antibiotic durations</intervention_name>
    <arm_group_label>4 weeks of treatment</arm_group_label>
    <arm_group_label>6 weeks of treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (≥17 years old)

          -  Total removal of the implant

        Exclusion Criteria:

          -  Primary native joint septic arthritis;

          -  Co-trimoxazole prophylaxis because of immunosuppression;

          -  Left-side endocarditis;

          -  Persistent implant material in the infected area.

          -  Infections with tuberculosis; mycobacteria; fungi; brucellosis; borreliosis;
             nocardiosis; and mycoplasmal osteosynthesis infections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilker Uçkay, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geneva University Hospitals</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Al-Mayahi M, Betz M, Müller DA, Stern R, Tahintzi P, Bernard L, Hoffmeyer P, Suvà D, Uçkay I. Remission rate of implant-related infections following revision surgery after fractures. Int Orthop. 2013 Nov;37(11):2253-8. doi: 10.1007/s00264-013-2092-1. Epub 2013 Sep 20.</citation>
    <PMID>24052163</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>January 17, 2017</study_first_submitted>
  <study_first_submitted_qc>July 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>July 30, 2018</last_update_submitted>
  <last_update_submitted_qc>July 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Ilker Uckay</investigator_full_name>
    <investigator_title>Attending, Docent Dr. med. Ilker Uçkay</investigator_title>
  </responsible_party>
  <keyword>implant-related infections</keyword>
  <keyword>orthopaedics</keyword>
  <keyword>implant removal</keyword>
  <keyword>antibiotic duration</keyword>
  <keyword>outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

